Drug search by name

C1 esterase inhibitor recombinant Intravenous and Thromboembolic events

Result of checking the interaction of drug C1 esterase inhibitor recombinant Intravenous and disease Thromboembolic events for safety when used together.

Check result:

C1 esterase inhibitor recombinant Intravenous <> Thromboembolic events

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Serious arterial and venous thromboembolic (TE) events have been reported at the recommended dose of C1 Esterase Inhibitor (Human) products. Benefits of C1 Esterase Inhibitor (Human) products for routine prophylaxis of hereditary angioedema attacks should be weighed against the risks of TE events in patients with underlying risk factors. It is recommended to monitor patients with known risk factors for thrombotic events.

C1 esterase inhibitor recombinant Intravenous

Generic Name: C1 esterase inhibitor (human)

Brand Name: Berinert, Cinryze, Haegarda, Ruconest

Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)

What is C1 esterase inhibitor recombinant Intravenous?